Use access key #2 to skip to page content.
$71.82 2.63 (3.80%)
7/8/2008 4:00 PM

Celgene Corp (CELG)

CAPS Rating:
*****

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

View All Commentary (CELG)

Recs

0

Avatar ypcheng (98.88) Submitted: 5/09/08 12:47 PM : Outperform Start Price: $61.92 CELG Score: 24.29

Reported decent quarterly report and the stock is down. Warren Buffett says: we love it when the price is down because it gets more interesting.

Report this Post Replies: 0 | Reply

Featured Broker Partners